Inflammation and Microflora
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in Gastroenterology Clinics of North America
- Vol. 40 (1), 69-85
- https://doi.org/10.1016/j.gtc.2010.12.010
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without ConstipationThe New England Journal of Medicine, 2011
- Treating irritable bowel syndrome with probiotics: the evidenceProceedings of the Nutrition Society, 2010
- Evaluating Breath Methane as a Diagnostic Test for Constipation-Predominant IBSDigestive Diseases and Sciences, 2009
- The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic reviewGut, 2008
- T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained ResponseGastroenterology, 2008
- Small intestinal bacterial overgrowth in patients with irritable bowel syndromeGut, 2007
- Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunumGut, 2007
- U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 1993
- Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.Gut, 1992
- Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis.Gut, 1986